Study protocol for developing a patient-reported outcome measure for infection screening in hematological patients with secondary immunodeficiency
Abstract Background Patients with chronic lymphocytic leukemia (CLL) or multiple myeloma (MM) frequently develop secondary immunodeficiencies (SID), on the basis of both their respective disease, as well as immunosuppressive therapies, leading to increased infection risks and impaired health-related...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2025-10-01
|
| Sarja: | BMC Cancer |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s12885-025-14996-y |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
